More COVID-19 vaccine supplies coming to the rescue of EU roll-out

17 February 2021
covid_big

The European Union’s roll-out of COVID-19 vaccines has been a disaster so far, and even European Commission President Ursula von der Leyen has conceded that the EU is “not where it wants to be” with its coronavirus immunization program.

She has admitted that “we were late to authorize,”.…“We were too optimistic when it came to massive production, and perhaps too confident that what we ordered would actually be delivered on time.”

But help seems to be on the horizon, as today suppliers of two vaccines authorized in Europe for conditional use upped their commitments.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology